May 03, 2022 / 02:00PM GMT
Jenene Thomas -
Good morning, everyone, and thank you for joining us today. I would like to welcome everyone to the Virtual Investor Management and KOL Roundtable, featuring Palisade Bio. My name is Jenene Thomas. I'm CEO of JTC IR, and I will be the moderator for today's event.
Joining me from Palisade Bio are Dr. Tom Hallam, Chief Executive Officer; Dr. Michael Dawson, Chief Medical Officer; Robert McRae, Senior Vice President of Operations and Strategic Development; as well as our participating key opinion leaders, we're pleased to have Dr. David Hoyt, Emeritus, Executive Director of the American College of Surgeons; and Dr. Steven Wexner, Director of Digestive Disease Center and Chair of the Department of Colorectal Surgery at the Cleveland Clinic in Florida.
So before we get started, I want to remind our audience that Palisade Bio is publicly listed on NASDAQ and trades under the ticker PALI. During today's discussion, the company will be making forward-looking statements, and I encourage everyone to review the company's latest SEC filings on their website at palisadebio.com for the latest
Palisade Bio Inc Key Opinion Leader Roundtable Event Transcript
May 03, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers